Collaboration 1 and 2 OcuLief (Re-Vana Therapeutics)
N/A
Report date: 2024/09/02 10:21:13
Base Information
Drug NameCollaboration 1 and 2 OcuLief (Re-Vana Therapeutics)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRe-Vana Therapeutics Ltd
China Registration ClassN/A
Develop Information
Active CompaniesRe-Vana Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A